Andere talen Eledon Pharmaceuticals, Inc.

Aandelen

ELDN

US28617K1016

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,39 ^USD	+0,84%		+10,65%	+32,78%

28/03	Eledon Pharmaceuticals, Inc. rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
25/03	Eledon Pharmaceuticals zegt dat 12e deelnemer is ingeschreven in Tegoprubart-studie; aandelen stijgen na de uren	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Eledon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results	28/03
Eledon Pharmaceuticals Says 12th Participant Enrolled in Tegoprubart Trial; Shares Rise After Hours	25/03
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection	25/03
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection	25/03
Sector Update: Health Care Stocks Higher in Late Afternoon Trading	21/03
Sector Update: Health Care	21/03
Eledon Pharmaceuticals Says Tegoprubart Used in Kidney Transplant From Pig to Human	21/03
USA-Un homme greffé avec le rein d'un porc, une première mondiale	21/03
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human	21/03
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human	21/03
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	14/02
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	14/02
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook	04/01
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05/12
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05/12
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference	29/11
Eledon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results	09/11
Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference	08/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Eledon Pharmaceuticals, Inc.

Aandelen

ELDN

US28617K1016

Andere talen

Filters